MedTrace Logo

Exercise and Movement to Enhance Resiliency in Cancer Patients

NCT06809933 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-01-26

No results posted yet for this study

Summary

This is a single-center, pilot, hybrid type 1 design implementation study to evaluate the feasibility and implementation of a personalized digital exercise program and a virtual support group to improve patient-centered outcomes in patients receiving treatment for gynecologic cancer receiving treatment at University of California, San Francisco.

Conditions

  • Gynecologic Cancer

Interventions

OTHER

Digital Health Mobile App

A digital health technology (DHT) called "Move" by Sword Health, which utilizes a mobile app displaying tailored and recommended exercise options, wearable technology (Move wearable or equivalent), and a web-based platform monitored by a physical therapist who will provide individual support

OTHER

Virtual Support Group

An institutional, virtual peer support group session will include a maximum of 5 participant per group

OTHER

Health Coaching

The facilitated group and discussions sessions will be led by a University of California, San Francisco (UCSF) certified health coach (CHC), following a pre-specified agenda and provided virtually

OTHER

FitBit

FitBit is a health and activity tracking device placed around the wrist

OTHER

Handouts

A handout with exercise recommendations for those with cancer in accordance with national guidelines

Sponsors & Collaborators

Principal Investigators

  • Stephanie Cham, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-24
Primary Completion
2031-08-31
Completion
2031-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06809933 on ClinicalTrials.gov